Adverse events · Patients with active Crohn's disease
Antibiotic with anti‐TNF showed no clear difference in adverse events compared with placebo with anti‐TNF (moderate certainty).
1 finding from 1 review
Serious adverse events · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Patients with active Crohn's disease
Antibiotic with anti‐TNF showed no clear difference in withdrawal due to adverse events compared with placebo with anti‐TNF (low certainty).
1 finding from 1 review
Failure to maintain remission · Patients with active Crohn's disease
Antibiotic showed no clear difference in failure to maintain clinical remission compared with placebo (low certainty).
1 finding from 1 review
Failure to achieve clinical response · Patients with active Crohn's disease
Antibiotic probably leads to lower failure to achieve clinical response compared with placebo (moderate certainty).
1 finding from 1 review
Failure to maintain endoscopic remission · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in adverse events compared with placebo (high certainty).
1 finding from 1 review
Serious adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Failure to induce clinical remission at end of study · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Failure to maintain remission · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Remission · Patients with active Crohn's disease
It is very uncertain whether intervention diet changes induction of remission at 4 weeks ‐ High‐fiber, low refined… compared with control diet (very low certainty).
4 findings from 1 review
Show 1 more finding
Clinical relapse · Participants with Crohn's disease in remission
Intervention diet showed no clear difference in clinical relapse at 6 to 24 months ‐ Symptoms‐guided diet compared with control diet (low certainty).
4 findings from 1 review
RR 0.53 [0.28, 1.01]
2 studies · 98 participants
Low
RR 1.03 [0.85, 1.26]
1 study · 214 participants
Low
RR 0.11 [0.01, 1.76]
1 study · 54 participants
Very low
Show 1 more finding
Health‐related quality of life · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Participants with Crohn's disease in remission
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Induction of remission (timeframe not reported) ‐ Symptoms‐guided diet · people with active UC
It is very uncertain whether intervention diet changes induction of remission ‐ Symptoms‐guided diet compared with control diet (very low certainty).
1 finding from 1 review
Health‐related quality of life · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical relapse · Patients with quiescent ulcerative colitis
It is very uncertain whether intervention diet changes clinical relapse at 6 months ‐ Anti‐inflammatory diet (Alberta‐based) compared with control diet (very low certainty).
3 findings from 1 review
RR 1.25 [0.42, 3.7]
1 study · 28 participants
Very low
RR 0.5 [0.15, 1.64]
1 study · 15 participants
Very low
RR 0.83 [0.6, 1.15]
2 studies · 77 participants
Low
Health related quality of life at 12 months ‐ SIBDQ ‐ Carrageenan‐free diet · Patients with quiescent ulcerative colitis
1 finding from 1 review